Condition
Aplastic Anemia Idiopathic
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (1)
P 2 (2)
P 3 (1)
Trial Status
Not Yet Recruiting3
Unknown2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07078721Phase 2Not Yet RecruitingPrimary
Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia
NCT06607367Phase 1Not Yet Recruiting
REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2
NCT06493981Phase 3Not Yet RecruitingPrimary
Outcomes in Bone Marrow Aplasia.
NCT04761965Not ApplicableUnknown
Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy
NCT03955601Phase 2UnknownPrimary
A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia:
Showing all 5 trials